| Date Initiated by Firm | February 01, 2023 |
| Date Posted | September 30, 2024 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-1286-2023 |
| Recall Event ID |
91745 |
| 510(K)Number | K953212 |
| Product Classification |
C-reactive protein, antigen, antiserum, and control - Product Code DCK
|
| Product | CRP Immunoturbidimetric reagent. Intended for the quantitative in vitro determination of CRP concentration in serum
Catalogue number: CP3826 |
| Code Information |
GTIN: 05055273201765
Batch: 588434
|
| FEI Number |
3003059701
|
Recalling Firm/ Manufacturer |
Randox Laboratories 515 Industrial Blvd Kearneysville WV 25430-2778
|
Manufacturer Reason for Recall | The Antibody (R2 reagent) is showing a positive bias compared to previous batches on patient samples. Quality Controls do not show the same bias and will be within range |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | Randox UK (manufacturer) extended Urgent Medical Device Removal letter to the US distributor via email on 2/1/23. The distributor contacted the customer via email on 2/6/23. Letter states reason for recall, health risk and action to take:
" Discontinue use of and discard any of the above immediately. Provide Randox with photographic evidence of the destruction of the kits.
" Review your reagent inventory of these products and assess your laboratories needs for reimbursement for discarded inventory.
" Review results generated with the affected batches in line with the clinical profile of the patient.
" Discuss the contents of this notice with your Medical Director.
" Complete and return the response form 12187-QA to technical.services@randox.com within five working days.
If you have any questions or concerns, please contact Randox Technical Services. |
| Quantity in Commerce | 2 kits |
| Distribution | PA, OH, WV |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = DCK
|